AN
About
Anbiping is a number of reagents and supporting devices have indeed been independently created by Anbiping, which focuses on tumour screening and correct diagnosis. Pathology is the main application department. It has been established that product lines for liquid-based cytology, polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization can be used to screen for and diagnose tumors based on everything from cell morphology to protein expression.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 37 investors are based in Huangpu, Shanghai, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Huangpu, China
Contact Information
linkedin.com/in/••••••••
Find more investors like Anbiping
Search Investors